Ultrasound-guided renal artery administration of angiopoietin-1 RNA therapy slows the progression of preclinical WT1 glomerular disease | Science Translational Medicine
Angiopoietin-1 RNA therapy slows the progression of WT1 glomerular disease in a preclinical mouse model.
